Volitionrx Ltd (VNRX)

Trade VNRX now with
7/14/2020 6:04:08 AM Volition Announces Results From Two Proof Of Concept Clinical Studies Using Its Nu.Q Assays
6/10/2020 9:42:28 AM Cotterford Says Voting Against Volition's Board Proposals At 2020 Annual Meeting
5/22/2020 4:03:23 PM VolitionRx Announces Closing Of $13.8 Mln Public Offering Of Common Stock
5/20/2020 8:47:41 AM VolitionRx Prices Public Offering Of 4.36 Mln Shares At $2.75/Shr
5/19/2020 4:05:42 PM VolitionRx Announces Proposed Underwritten Public Offering Of Common Stock
4/23/2020 8:32:11 AM Volition Files Patent For Nu.Q(TM) COVID-19 Triage Test And Commences Proof Of Concept Studies
2/18/2020 8:30:00 AM Volition Unveils Its Epigenetic Toolbox (Press Release)
10/9/2019 4:13:10 PM Volition Appoints Phillip Barnes To Board Of Directors
9/17/2019 8:37:05 AM VolitionRx Announces Significant Milestone In Its Nu.Q Capture Development Program
7/18/2019 8:32:54 AM VolitionRx Begins Lung Cancer Clinical Study With Fosun Long March In China
7/10/2019 8:32:21 AM VolitionRx Secures Additional $1.4 Mln In Non-Dilutive Funding
4/9/2019 8:36:03 AM VolitionRx Signs MoU With Texas A&M University For Potential Collaboration To Develop Nu.QTM Veterinary Diagnostics
4/3/2019 8:31:23 AM VolitionRx Limited Extends Clinical Trial Program In Lung Cancer